New Issue: Depomed closes $20 million direct placement

By Sheri Kasprzak

New York, April 23 - Depomed, Inc. wrapped a direct placement for $20,007,500.

The company sold 5.3 million shares at $3.775 each.

The offering was not brokered and the shares were sold under the company's shelf registration.

Depomed, based in Menlo Park, Calif., develops extended-release formulations of existing drugs.

Issuer:	Depomed, Inc.
Issue:	Stock
Amount:	$20,007,500
Shares:	5.3 million
Price:	$3.775
Warrants:	No
Placement agent:	Non-brokered
Settlement date:	April 23
Stock symbol:	Nasdaq: DEPO
Stock price:	$3.98 at close April 23

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.